Oncogenic <i>KRAS</i> and <i>BRAF</i> Differentially Regulate Hypoxia-Inducible Factor-1α and -2α in Colon Cancer
Hirotoshi Kikuchi(Massachusetts General Hospital), Daniel C. Chung(Massachusetts General Hospital), Senji Shirasawa(Harvard University), Maria Simona Pino(Massachusetts General Hospital), Min Zeng(University of Science and Technology of China)
Cited by 114
Related Papers
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
|Cell Host & Microbe|2013|2.7k
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
|Nature Medicine|2004|2k
Gastroenteropancreatic neuroendocrine tumours
|The Lancet Oncology|2008|1.8k
Celecoxib for the Prevention of Sporadic Colorectal Adenomas
|New England Journal of Medicine|2006|1k
The Chromosomal Instability Pathway in Colon Cancer
|Gastroenterology|2010|932